02272nam 2200541 450 991082078350332120230803024252.01-78084-189-2(CKB)2560000000152109(EBL)1179648(SSID)ssj0001599933(PQKBManifestationID)16306834(PQKBTitleCode)TC0001599933(PQKBWorkID)14892902(PQKB)10768650(MiAaPQ)EBC1179648(Au-PeEL)EBL1179648(OCoLC)877767242(EXLCZ)99256000000015210920220517d2013 uy 0engur|n|---|||||txtccrGout /editors, Nicola Dalbeth, Fernando Perez-Ruiz, Naomi Schlesinger1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (246 p.)Description based upon print version of record.1-78084-191-4 Title page; Copyright page; Contents; Foreword. Gout; 1. Epidemiology of gout; 2. Pathological basis of hyperuricemia and gout; 3. Pathophysiology and immunology of acute and chronic gout; 4. An update on the genetic causes of hyperuricemia and gout; 5. Clinical features of gout; 6. Synovial fluid analysis and crystal identification; 7. Imaging of gout; 8. Outcome measures in gout; 9. The patient's perspective of gout; 10. Asymptomatic hyperuricemia and its clinical implications for extra-articular disease; 11. Principles of gout management12. Urate-lowering therapy: xanthine oxidase inhibitors13. Urate-lowering therapy: uricosurics; 14. Urate-lowering therapy: uricases; 15. Therapies for acute flares and gout flare prophylaxis; 16. Gout comorbidities: prevalence and management; 17. Emerging therapeutics for acute and chronic gout; IndexGoutGoutGout.616.3999Dalbeth NicolaPerez-Ruiz FernandoSchlesinger NaomiMiAaPQMiAaPQMiAaPQBOOK9910820783503321Gout4005003UNINA